Evidence map›Paper›PMID 36012551›Full record

ArticleInternational journal of molecular sciences2022

The Effect of the Topmost Layer and the Type of Bone Morphogenetic Protein-2 Immobilization on the Mesenchymal Stem Cell Response.

Magdalena Wytrwal-Sarna, Małgorzata Sekuła-Stryjewska, Agata Pomorska, Ewa Ocłoń, Katarzyna Gajos, Michal Sarna, Ewa Zuba-Surma, Andrzej Bernasik, Krzysztof Szczubiałka

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Polymer Nanomaterials in Biomedicine.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Magdalena Wytrwal-SarnaAcademic Centre for Materials and Nanotechnology, AGH University of Science and Technology, Al. A. Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0002-0906-4532
Małgorzata Sekuła-StryjewskaMalopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7A, 30-387 Krakow, Poland.
Agata PomorskaJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, 30-239 Krakow, Poland.ORCID 0000-0003-0029-4013
Ewa OcłońLaboratory of Recombinant Proteins Production, Centre for Experimental and Innovative Medicine, University of Agriculture in Krakow, 1C Redzina Street, 30-248 Krakow, Poland.
Katarzyna GajosMarian Smoluchowski Institute of Physics, Jagiellonian University, Stanislawa Łojasiewicza 11, 30-348 Krakow, Poland.
Michal SarnaFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.ORCID 0000-0001-9306-7965
Ewa Zuba-SurmaFaculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.ORCID 0000-0001-6814-6127
Andrzej BernasikFaculty of Physics and Applied Computer Science, AGH University of Science and Technology, Reymonta 19, 30-059 Krakow, Poland.
Krzysztof SzczubiałkaFaculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland.ORCID 0000-0001-6612-1102
Jagiellonian University · PLAGH University of Krakow · PLJerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences · PLUniversity of Agriculture in Krakow · PL

Funding

National Science Center 2016/21/D/ST5/01636
6 · The paper itself

Abstract

Recombinant human bone morphogenetic protein-2 (rhBMP-2) plays a key role in the stem cell response, not only via its influence on osteogenesis, but also on cellular adhesion, migration, and proliferation. However, when applied clinically, its supra-physiological levels cause many adverse effects. Therefore, there is a need to concomitantly retain the biological activity of BMP-2 and reduce its doses. Currently, the most promising strategies involve site-specific and site-directed immobilization of rhBMP-2. This work investigated the covalent and electrostatic binding of rhBMP-2 to ultrathin-multilayers with chondroitin sulfate (CS) or diazoresin (DR) as the topmost layer. Angle-resolved X-ray photoelectron spectroscopy was used to study the exposed chemical groups. The rhBMP-2 binding efficiency and protein state were studied with time-of-flight secondary ion mass spectrometry. Quartz crystal microbalance, atomic force microscopy, and enzyme-linked immunosorbent assay were used to analyze protein-substrate interactions. The effect of the topmost layer was tested on initial cell adhesion and short-term osteogenesis marker expression. The results show the highest expression of selected osteomarkers in cells cultured on the DR-ended layer, while the cellular flattening was rather poor compared to the CS-ended system. rhBMP-2 adhesion was observed only on negatively charged layers. Cell flattening became more prominent in the presence of the protein, even though the osteogenic gene expression decreased.

Indexed as

Bone Morphogenetic Protein 2Mesenchymal Stem CellsCell AdhesionCell DifferentiationCells, CulturedChondroitin SulfatesHumansOsteogenesisRecombinant ProteinsStem CellsTransforming Growth Factor betaBone Morphogenetic Protein 2Chondroitin SulfatesRecombinant ProteinsTransforming Growth Factor betaAR-XPSbone morphogenetic protein 2cell culture surfaceschondroitin sulfatediazoresinTOF-SIMS

Identifiers

PMID36012551
PMCPMC9408842
OpenAlexW4292247336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.